🇮🇳IN
Sign In
NA

NATHBIOGEN

NSE

Nath Bio-Genes (India) Limited

₹132.67

+1.25(+0.95%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

NATHBIOGEN financial summary

For Mar 2026, Nath Bio-Genes (India) Limited reported revenue of ₹345 crore, which grew 30.2% from the previous year. Net profit was ₹44 crore, which grew 4.8% year on year, on an operating margin of 15%. Earnings per share came in at ₹23.38. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹345 crore
Net profit₹44 crore
Operating margin15%
EPS₹23.38

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer